XML 52 R28.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION PLAN
12 Months Ended
Dec. 31, 2021
SHARE-BASED COMPENSATION PLAN  
SHARE-BASED COMPENSATION PLAN

22.

SHARE-BASED COMPENSATION PLAN

For the year ended December 31, 2021, the Company has 3 (three) share-based, long-term compensation plans, (i) Phantom stock option plan (“PS”) and (ii) Share Appreciation Rights (“SAR”), both settled in local currency and (iii) restricted shares, settled in shares.

The characteristics and measurement method of such each plan are disclosed below.

22.1.

Long term compensation plans (“PS and SAR”)

Certain executives and key members of the Management have a long-term compensation plan linked to the share price with payment in cash.

Throughout 2020, the Company granted the SAR and PLUS (Share Appreciation Rights) (“SAR”) plans of phantom stock options. In this plan,

In the PS plan, the beneficiary does not make any investment and in the SAR plan, the beneficiaries should invest 5% of the total amount corresponding to the number of options of phantom shares at the grant date and 20% after 3 (three) years to acquire the option. The Company also granted long-term incentive plans to its key members as part of its retention policy.

The vesting period of options may vary from 3 (three) to 5 (five) years, as of the grant date, in accordance with the characteristics of each plan.

The price of the share is calculated based on the average share quote of the 90 previous trading sessions starting from the closing quote on the last business day of the month prior to the month of the grant. The installments of these programs will be adjusted by the variation in the price of the SUZB3 at B3, between the granting and the payment period. On dates when the SUZB3 shares is not traded, the quote of the previous trading session will be considered.

The phantom share options will only be due if the beneficiary is an employee of the Company on the payment date. In case of termination of the employment by initiative of the Company or by initiative of the beneficiary, before the vesting period is completed, the executive will not be entitled to receive all benefits, unless otherwise established in the agreements.

The rollforward is set forth below:

December 31,

December 31,

December 31,

    

2021

    

2019

    

2018

Number of shares

Beginning balance

5,772,356

5,996,437

5,045,357

Granted during of the year

1,906,343

1,770,384

2,413,038

Exercised (1)

(1,860,334)

(1,789,413)

(827,065)

Exercised due to resignation (1)

(86,196)

(21,253)

(106,983)

Abandoned / prescribed due to resignation

(316,415)

(183,799)

(527,910)

Ending balance

5,415,754

5,772,356

5,996,437

1)The average price for  share options exercised and exercised due to termination of employment, for  the year ended December 31, 2021 was R$60,30 (sixty Brazilian Reais and thirty cents) ((R$43.14 (forty-three Brazilian Reais and fourteen cents) as of December 31, 2020).

On December 31, 2021, the consolidated outstanding phantom shares option plans are as set forth below:

December 31, 2021

Quantity of

    

    

Fair value on

    

outstanding options

Plan

Grant date

Exercise date

grant date (1)

granted

SAR 2017

04/03/2017

04/03/2022

R$

13.30

7,405

ILP 2017 - 60

04/03/2017

04/03/2022

R$

13.30

304,512

Diferral 2017

03/01/2018

03/01/2022

R$

19.88

154,242

SAR 2018

04/02/2018

04/02/2023

R$

21.45

36,231

ILP 2019 - 36

03/01/2019

03/01/2024

R$

41.10

470,000

Diferral 2018

03/01/2019

03/01/2022

R$

41.10

82,725

Diferral 2018

03/01/2019

03/01/2023

R$

41.10

82,725

ILP 2019 - 36 H

03/25/2019

03/25/2024

R$

42.19

7,500

ILP 2019 - 48 H

03/25/2019

03/25/2024

R$

42.19

7,500

ILP 2019 - 36 Apr

04/01/2019

04/01/2024

R$

42.81

20,000

SAR 2019

04/01/2019

04/01/2024

R$

42.81

669,656

PLUS 2019

04/01/2019

04/01/2024

R$

42.81

15,572

ILP 2019 - 36 Oct

10/01/2019

10/01/2022

R$

31.75

19,500

ILP 2019 - 48 Oct

10/01/2019

10/01/2023

R$

31.75

11,700

ILP 2020 - 36 Apr

04/01/2020

04/01/2023

R$

38.50

82,666

ILP 2020 - 24 Apr

04/01/2020

04/01/2022

R$

38.50

21,250

SAR 2020

04/01/2020

04/01/2025

R$

38.50

666,828

ILP 2020- 48 Condition A

05/01/2020

04/30/2024

R$

38.34

595,000

ILP 2020- 48 Condition B

05/01/2020

04/30/2024

R$

38.34

127,500

ILP 2020- 48 Condition C

05/01/2020

04/30/2024

R$

38.34

127,500

ILP - Retention 2020 - 36 Oct

10/01/2020

10/01/2023

R$

38.79

31,792

ILP Retention 2020 - Bond premium and offer

10/01/2020

10/01/2023

R$

43.14

4,581

ILP Hiring/Retention Bonus 2020 - 36 Oct

10/01/2020

10/01/2023

R$

43.14

6,954

Deferral 2020

03/01/2021

03/01/2024

R$

57.88

292,428

Deferral 2020

03/01/2021

03/01/2025

R$

57.88

292,428

ILP 2021 - 24

03/01/2021

03/01/2023

R$

56.10

6,000

ILP 2021 - 36

03/01/2021

03/01/2024

R$

56.10

6,000

ILP 2021 - 36 Apr

04/01/2021

04/01/2024

R$

64.12

260,000

ILP 2021 - 48 Apr

04/01/2021

04/01/2025

R$

64.12

210,000

ILP 2021 - 12 May

05/01/2021

05/01/2022

R$

67.91

750

ILP 2021 - 24 May

05/01/2021

05/01/2023

R$

67.91

625

ILP 2021 - 36 May

05/01/2021

05/01/2024

R$

67.91

1,125

SAR 2021

04/01/2021

04/01/2026

R$

64.12

758,660

ILP Retention 2021 - Jul

07/01/2021

07/01/2024

R$

67.72

8,130

ILP Retention 2021 - Aug

08/01/2021

08/01/2024

R$

63.73

3,789

ILP - Retention 2021 - 36 Oct

10/01/2021

10/01/2024

R$

58.05

2,412

ILP 2021 - Apr 23/24

12/16/2021

04/03/2023

R$

54.81

10,034

ILP 2021 - Apr 23/24

12/16/2021

04/01/2024

R$

54.81

10,034

5,415,754

(1)Amounts expressed in Reais.

22.2

Restricted shares plan

The Company also offers a Restricted Shares plan based on the Company's performance (Program Restricted Shares). The plan associates the quantity of restricted shares granted to the Company's performance, which in 2021 was in relation to the operating cash generation target and ESG. The quantity of the restricted stock granted is defined in financial terms and is subsequently converted into shares based on the last 60 (sixty) stock exchange trading days on December 31, 2021 of SUZB3 at B3.

After measurement of the target, that occurs 12 months after the execution of the contract, the restricted shares will be granted immediately (conditioned to the achievement of the established goals), as they not have to comply to the vesting period. However, the beneficiaries of the grant must comply to the lockup period of thirty-six (36) months during which they will not be able to market the shares.

In the event that the beneficiaries leave the Company before the end of the fiscal year for the measurement of operating cash generation, they will lose the right to the grant of restricted share.

The position is set forth below:

Date of the

execution of

Price on

Shares

Restricted year for

Program

    

the contract

    

Grant date

    

grant date

    

Granted

    

transfer of shares

2018

01/02/2018

01/02/2019

R$

39.10

130,435

01/02/2022

2019

01/02/2020

01/02/2021

R$

51.70

106,601

01/02/2024

2021

01/02/2021

01/02/2022

R$

53.81

90,005

01/02/2025

22.3

Measurement assumptions

In the case of the phantom shares plan, since the settlement is in cash, the fair value of options is remeasured at the end of each period based on the Monte Carlo Method (“MMC”), which is multiplied by the Total Shareholder Return (“TSR”) in the period which varies between 75% and 125%, depending on the performance of SUZB3 in relation to its peers in Brazil.

The restricted stock plan considers the following assumptions:

(i)the expectation of volatility was calculated for each exercise date, considering the remaining time to complete the vesting year, as well as the historical volatility of returns, using the GARCH model for calculating volatility;
(ii)the expectation of average life of phantom stocks and stock options was defined by the remaining term until the limit exercise date;
(iii)the expectation of dividends was defined based on historical earnings per share of the Suzano;  and
(iv)risk-free weighted average interest rate used was the Brazilian Reais yield curve (DI expectation) observed on the open market, which is the best comparison basis with the Brazilian market risk-free interest rates. The rate used for each exercise date changes according to the vesting year.

The amounts corresponding to the services received and recognized are set forth below:

Liabilities and Equity

Statement of income and Equity

December 31,

December 31,

December 31,

December 31,

December 31,

    

2021

    

2020

    

2021

    

2020

    

2019

Non-current liabilities

Provision for phantom stock plan

166,998

195,135

(94,897)

(151,985)

(46,389)

Equity

Stock option granted

15,455

10,612

(4,843)

(4,633)

(879)

Total general and administrative expenses from share-based transactions

(99,740)

(156,618)

(47,268)